Clinical and pharmacokinetics overview of intranasal administration of fentanyl☆

Samaneh Nakhaee, Farhad Saeedi, Omid Mehrpour · 2023

Read Clinical and pharmacokinetics overview of intranasal administration of fentanyl☆ by Samaneh Nakhaee, Farhad Saeedi, Omid Mehrpour (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10746457.txt.

Description

Samaneh Nakhaee and co-authors review fentanyl given through the nose, in a 2023 paper. The nose offers a wide, blood-rich surface, so drugs act fast there. Nasal delivery also skips the liver's first pass, which raises how much drug reaches the blood. Fentanyl's traits made it a strong candidate for this route.

Approved nasal products in Europe and the United States serve cancer pain and severe sudden pain in emergency care. Trials found nasal and intravenous fentanyl similar in onset and duration for breakthrough cancer pain. Nasal spray reached blood levels faster than a mouth-based form. Side effects center on the nose and throat, plus nausea. The authors note that reports on rare serious harms stay thin.

Catalog record

CREATORSamaneh Nakhaee, Farhad Saeedi, Omid Mehrpour
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10746457

Browse the full library · About the Tower of Babel